x
[contact-form-7 404 "Not Found"]

Category: Recent Posts

Recent Posts Cancer

May2023

Tersan Pharmaceuticals Ltd continues to bolster Scientific Advisory Board by adding world-leading Oncologist Pr. Jean-Yves BLAY

Tersan Pharmaceuticals Ltd is a leading Artificial Intelligence (AI) drug development company. Using its KEM® Artificial Intelligence (xAI) technology, Tersan helps its partners introduce personalized medicine clinical trial design into their protocols and optimize clinical endpoints, identify biomarkers of therapeutic response and potential synergistic therapies. Tersan routinely collects and combines clinical data with omic data, immunological […]

Read More
Recent Posts

Mar2023

Tersan Pharmaceuticals Ltd strengthens SAB with appointment of world-leading Neurologist Jacques Touchon

Cambridge, MA, USA and Paris, France, March 27, 2023 – Tersan Pharmaceuticals Ltd, the leading Al-driven precision medicine company, has announced the appointment of Professor Jacques Touchon to its Scientific Advisory Board.

Read More
Recent Posts

Jul2022

Tersan Pharmaceuticals Ltd strengthens management team with appointments of VP Business Development and Chief Financial Officer

Paris, France and Cambridge, MA, USA, July 26th, 2022 – Tersan Pharmaceuticals Ltd, the leading eXplainable Artificial Intelligence (xAI) drug development company, announce the appointments of Dr. Marion Soto as Vice President, Business Development and Bertrand Lellouche as Chief Financial Officer. The financial and commercial experience of Marion and Bertrand will further drive Tersan’s accelerated growth. […]

Read More